Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
S Wang, B Liang, W Wang, L Li, N Feng… - Signal transduction and …, 2023 - nature.com
Human diseases, particularly infectious diseases and cancers, pose unprecedented
challenges to public health security and the global economy. The development and …
challenges to public health security and the global economy. The development and …
Ebola virus disease
Ebola virus disease (EVD) is a severe and frequently lethal disease caused by Ebola virus
(EBOV). EVD outbreaks typically start from a single case of probable zoonotic transmission …
(EBOV). EVD outbreaks typically start from a single case of probable zoonotic transmission …
Current state of Ebola virus vaccines: A snapshot
C Woolsey, TW Geisbert - PLoS pathogens, 2021 - journals.plos.org
Four species of the genus Ebolavirus cause severe and often lethal disease in humans:
Sudan ebolavirus (SUDV), Bundibugyo ebolavirus (BDBV), Taï Forest ebolavirus (TAFV) …
Sudan ebolavirus (SUDV), Bundibugyo ebolavirus (BDBV), Taï Forest ebolavirus (TAFV) …
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control
S Wang, W Li, Z Wang, W Yang, E Li, X **a… - Signal transduction and …, 2024 - nature.com
To adequately prepare for potential hazards caused by emerging and reemerging infectious
diseases, the WHO has issued a list of high-priority pathogens that are likely to cause future …
diseases, the WHO has issued a list of high-priority pathogens that are likely to cause future …
Immunovirotherapy based on recombinant vesicular stomatitis virus: where are we?
Y Zhang, BM Nagalo - Frontiers in immunology, 2022 - frontiersin.org
Vesicular stomatitis virus (VSV), a negative-strand RNA virus of the Vesiculovirus genus, has
demonstrated encouraging anti-neoplastic activity across multiple human cancer types. VSV …
demonstrated encouraging anti-neoplastic activity across multiple human cancer types. VSV …
Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
A Fathi, C Dahlke, MM Addo - Human vaccines & …, 2019 - Taylor & Francis
The devastating Ebola virus (EBOV) outbreak in West Africa in 2013–2016 has flagged the
need for the timely development of vaccines for high-threat pathogens. To be better …
need for the timely development of vaccines for high-threat pathogens. To be better …
A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge
Background Marburg virus (MARV), an Ebola-like virus, remains an eminent threat to public
health as demonstrated by its high associated mortality rate (23–90%) and recent …
health as demonstrated by its high associated mortality rate (23–90%) and recent …
Oral delivery of a chitosan adjuvanted COVID-19 vaccine provides long-lasting and broad-spectrum protection against SARS-CoV-2 variants of concern in golden …
S Wang, H Cui, C Zhang, W Li, W Wang, W He, N Feng… - Antiviral Research, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) seriously threatens public health safety and
the global economy, which warrant effective prophylactic and therapeutic approaches …
the global economy, which warrant effective prophylactic and therapeutic approaches …
Prevention of Ebola virus disease through vaccination: where we are in 2018
Y Lévy, C Lane, P Piot, AH Beavogui, M Kieh, B Leigh… - The Lancet, 2018 - thelancet.com
In 2016, Guinea, Liberia, and Sierra Leone succeeded in interrupting the longest epidemic
of Ebola virus disease in global history. 1 Control of the epidemic was primarily achieved by …
of Ebola virus disease in global history. 1 Control of the epidemic was primarily achieved by …
Immunogenicity, lot consistency, and extended safety of rVSVΔG-ZEBOV-GP vaccine: a phase 3 randomized, double-blind, placebo-controlled study in healthy adults
SA Halperin, R Das, MT Onorato, K Liu… - The Journal of …, 2019 - academic.oup.com
Background This double-blind study assessed immunogenicity, lot consistency, and safety
of recombinant vesicular stomatitis virus-Zaire Ebola virus envelope glycoprotein vaccine …
of recombinant vesicular stomatitis virus-Zaire Ebola virus envelope glycoprotein vaccine …